Factors Regulated by Interferon Gamma and Hypoxia-inducible Factor 1A Contribute to Responses That Protect Mice from Coccidioides Immitis Infection
Overview
Authors
Affiliations
Background: Coccidioidomycosis results from airborne infections caused by either Coccidioides immitis or C. posadasii. Both are pathogenic fungi that live in desert soil in the New World and can infect normal hosts, but most infections are self-limited. Disseminated infections occur in approximately 5% of cases and may prove fatal. Mouse models of the disease have identified strains that are resistant (e.g. DBA/2) or susceptible (e.g. C57BL/6) to these pathogens. However, the genetic and immunological basis for this difference has not been fully characterized.
Results: Microarray technology was used to identify genes that were differentially expressed in lung tissue between resistant DBA/2 and sensitive C57BL/6 mice after infection with C. immitis. Differentially expressed genes were mapped onto biological pathways, gene ontologies, and protein interaction networks, which revealed that innate immune responses mediated by Type II interferon (i.e., IFNG) and the signal transducer and activator of transcription 1 (STAT1) contribute to the resistant phenotype. In addition, upregulation of hypoxia inducible factor 1A (HIF1A), possibly as part of a larger inflammatory response mediated by tumor necrosis factor alpha (TNFA), may also contribute to resistance. Microarray gene expression was confirmed by real-time quantitative PCR for a subset of 12 genes, which revealed that IFNG HIF1A and TNFA, among others, were significantly differentially expressed between the two strains at day 14 post-infection.
Conclusion: These results confirm the finding that DBA/2 mice express more Type II interferon and interferon stimulated genes than genetically susceptible strains and suggest that differential expression of HIF1A may also play a role in protection.
Single-cell analysis of human airway epithelium identifies cell type-specific responses to and .
Harding A, Crossen A, Reedy J, Basham K, Hepworth O, Zhang Y bioRxiv. 2024; .
PMID: 39314271 PMC: 11418999. DOI: 10.1101/2024.09.09.612147.
The Host Response to Coccidioidomycosis.
Kirkland T, Hung C, Shubitz L, Beyhan S, Fierer J J Fungi (Basel). 2024; 10(3).
PMID: 38535182 PMC: 10971205. DOI: 10.3390/jof10030173.
Carlin A, Viriyakosol S, Okamoto S, Walls L, Fierer J Infect Immun. 2020; 89(1).
PMID: 33106296 PMC: 7927936. DOI: 10.1128/IAI.00883-19.
A Chronic Murine Disease Model of Coccidioidomycosis Using Coccidioides posadasii, Strain 1038.
Shubitz L, Powell D, Butkiewicz C, Lewis M, Trinh H, Frelinger J J Infect Dis. 2020; 223(1):166-173.
PMID: 32658292 PMC: 7781464. DOI: 10.1093/infdis/jiaa419.
HIF-1α as a central mediator of cellular resistance to intracellular pathogens.
Knight M, Stanley S Curr Opin Immunol. 2019; 60:111-116.
PMID: 31229914 PMC: 8592400. DOI: 10.1016/j.coi.2019.05.005.